A 78-year-old woman who was receiving corticosteroids for rheumatoid arthritis was admitted to our hospital to have her fever, hemoptysis, diarrhea, and chest x-ray abnormalities, which were unresponsive to antibiotics, investigated. A chest computed tomography scan revealed infiltrative shadows and a large cavity in the right lower lobe. Laboratory tests revealed a white blood cell count of 13,100/μL, a serum C-reactive protein level of 8.75 mg/dL, a serum albumin level of 1.4 g/ dL, and positivity for Cryptococcus antigen. Grocott staining of a transbronchial lung biopsy specimen detected black-brown fungi. Also, a stool sample was positive for Clostridium difficile toxin, leading to a diagnosis of pulmonary cryptococcosis and pseudomembranous colitis. The patient was given 200 mg/day intravenous fosfluconazole and 1500 mg/day oral metronidazole, and her condition improved. Immunocompromised hosts with pulmonary cryptococcosis demonstrate a wide variety of radiographic abnormalities, including nodules, cavitation, and infiltration.
Introduction
Cryptococcosis is a fungal infection that can result in pulmonary involvement after the inhalation of Cryptococcus spores. Immunocompetent patients tend to exhibit peripheral nodule(s) on radiographic imaging. In contrast, immunocompromised hosts demonstrate a wide variety of radiographic abnormalities, including nodules, infiltration, consolidation, cavitation, adenopathy, and pleural effusion [1] [2] [3] . Here, we report a case of pulmonary cryptococcosis involving the formation of a large cavity.
Case Report
A 78-year-old woman was admitted to another hospital because of general fatigue in January 2012. She had been receiving corticosteroids (5 mg/day prednisolone) for rheumatoid arthritis for 3 months. A chest x-ray and computed tomography (CT) scan depicted regions of airspace consolidation in the right lower lobe (Figs. 1, 2, left) . Thus, bacterial pneumonia was suspected, and intravenous antibiotics, including 6 g/day ampicillin/sulbactam, 13.5 g/day piperacillin/tazobactam, and 1.5 g/day meropenem, were administered for more than 2 months; however, the patient's radiographic findings did not improve, and she developed fever, hemoptysis, and diarrhea. Thus, she was transferred to our hospital for investigation and treatment in March. A physical examination demonstrated the following results: temperature: 37.2°C, oxygen saturation level: 95%, and blood pressure: 82/41 mm Hg. A chest CT scan revealed regions of consolidation and a large cavity (70 × 50 mm in diameter) in the right lower lobe (Fig. 2 , middle). In addition, laboratory tests detected a white blood cell count of 13,100/μL, a serum C-reactive protein level of 8.75 mg/dL, a serum albumin level of 1.4 g/dL, and a serum carcinoembryonic antigen level of 1.3 ng/mL. Furthermore, serological tests produced negative results for human immunodeficiency virus and (1-3)-β-D glucan (<11.0 pg/mL), but a positive result for Cryptococcus antigen. Cultures of the patient's sputum were positive for Klebsiella pneumoniae (1+) but negative for fungal and mycobacterial pathogens. Also, a stool sample was found to be positive for Clostridium difficile toxin. To rule out tuberculosis, aspergillosis, lung cancer, and other diseases, bronchoscopy was performed. Grocott staining of a transbronchial lung biopsy specimen obtained from the abovementioned cavity detected black-brown fungi. Based on these results, the patient was diagnosed with pulmonary cryptococcosis and pseudomembranous colitis, and treatment with intravenous fosfluconazole (loading doses of 400 mg on days 1 and 2 followed by 200 mg for 20 days) and oral metronidazole (1500 mg/day for 6 weeks) was started. As a result, her condition, laboratory data, and radiographic findings gradually improved. Then, the 200 mg/day intravenous fosfluconazole was switched to 400 mg/day oral fluconazole and the patient was discharged in May. By November, the large cavity had disappeared (Fig. 2, right) . Oral fluconazole has been continued until now.
Discussion
Pulmonary cryptococcosis is known to occur in people with acquired immunodeficiency syndrome and those in immunocompromised states, such as patients undergoing organ transplantation or those on immunosuppressive regimens; however, it can also occur in immunocompetent subjects. Single or multiple pulmonary nodules are the most common findings in immunocompetent hosts, whereas immunocompromised hosts demonstrate a wide variety of radiographic abnormalities, including single or multiple nodules that progress to confluence and/or cavitation, segmental consolidation, bilateral bronchopneumonia, or mixed patterns [1] . A previous study reported that cavitation within nodules and parenchymal consolidation were significantly less common in immunocompetent patients than in immunocompromised patients [2] . In another retrospective evaluation of 76 patients with a tissue-confirmed pulmonary cryptococcosis, including 35 immunocompromised and 41 immunocompetent patients, cavitation was significantly more common among the immunocompromised patients (eight patients) than among the immunocompetent patients (two patients) [3] .
In the present case, an immunocompromised patient with rheumatoid arthritis had been treated with several antibiotics for bacterial pneumonia for 2 months; however, the regions of airspace consolidation within her right lung were unresponsive, and a cavity measuring 70 × 50 mm in diameter developed. Finally, she developed pseudomembranous colitis with severe hypoalbuminemia. Fortunately, after being diagnosed with pulmonary cryptococcosis and treated accordingly, her condition gradually improved. This case indicates the importance of reevaluating the causative pathogen in cases of infection in which the initial treatment fails to produce a response.
In conclusion, clinicians should keep in mind that: (1) in immunocompromised patients, pulmonary cryptococcosis can present as regions of airspace consolidation that progress to cavitation; and (2) fungal infections have to be ruled out in cases of pulmonary infection involving infiltrative shadows or cavitation that are unresponsive to antibiotics.
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